Treace Medical Concepts, Inc. (TMCI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

6.17

-0.10

(-1.59%)

At close: 04:00PM EDT

6.17

0.00

(0.00%)

After hours:

04:03PM EDT

Loading interactive chart…

GlobeNewswire
Treace Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
PONTE VEDRA, Fla., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty® Procedures, today announced that John T. Treace, Chief Executive Officer, and Mark L. Hair, Chief Financial Officer, will participate in a fireside chat at the Morgan Stanley 22nd Annual Global
Simply Wall St.
Insider Buys Additional US$510k In Treace Medical Concepts Stock
Treace Medical Concepts, Inc. ( NASDAQ:TMCI ) shareholders (or potential shareholders) will be happy to see that the...
Simply Wall St.
Treace Medical Concepts Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Treace Medical Concepts ( NASDAQ:TMCI ) Second Quarter 2024 Results Key Financial Results Revenue: US$44.5m (up 6.0...